凯赛生物 (688065.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(凯赛生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 684,521,536.952,114,174,868.811,565,490,018.661,030,429,978.96505,446,207.402,441,103,971.541,837,722,247.371,288,863,796.70661,266,387.34
 营业利润(元) 123,463,826.25454,295,171.08398,542,878.66299,247,585.3279,088,998.60708,283,797.31635,480,343.23443,993,132.04215,520,226.25
 利润总额(元) 123,794,910.83448,924,542.25392,316,413.35294,830,632.3879,202,000.69695,991,911.20624,095,085.00428,726,122.06215,890,400.50
 净利润(元) 106,857,611.48408,535,593.14353,343,925.28264,468,200.8271,853,071.41612,654,860.45530,803,141.96368,341,273.84191,350,168.47
 归属于母公司股东的净利润(元) 105,258,699.94366,524,351.34313,885,180.71241,857,712.9857,441,388.49553,265,973.38486,180,697.60336,452,143.62174,549,406.71
盈利能力:
 销售毛利率(%) 28.6828.7928.4829.7334.0335.2435.4235.0736.10
 销售净利率(%) 15.6119.3222.5725.6714.2225.1028.8828.5828.94
 净资产收益率(%) 0.953.312.852.210.53----
 总资产报酬率ROA(%) 0.471.301.060.720.30----
 投入资本回报率ROIC(%) 0.812.932.541.960.474.714.172.901.52
营运能力:
 存货周转率(次) 0.330.990.730.500.23----
 应收账款周转率(次) 2.176.674.653.471.44----
 总资产周转率(次) 0.040.120.090.060.03----
偿债能力:
 资产负债率(%) 20.1621.5618.7817.8416.9515.6413.4911.129.38
 股东权益比率(%) 60.4459.2859.2559.9360.5061.4262.9564.5466.03
 已获利息倍数(倍) -2.31-1.12-0.96-0.75-1.96-1.36-1.21-1.48-2.67
 流动比率 2.602.222.783.184.875.957.659.4210.43
 速动比率 2.071.782.222.573.914.816.277.979.08
发展能力:
 营业收入增长率(%) 35.43-13.39-14.81-20.05-23.563.284.7913.5335.77
 营业利润增长率(%) 56.11-35.86-37.28-32.60-63.30-2.0811.8621.1331.77
 税后利润增长率(%) 83.25-33.75-35.44-28.12-67.09-6.972.157.7123.54
 净资产增长率(%) 2.201.972.362.951.552.793.163.682.98
 总资产增长率(%) 2.305.648.7410.8810.8310.1515.2923.6127.82

前瞻产业研究院